Zydus Cadila’s Covid vaccine to be administered only to adults as of now

Zydus Cadila’s Covid vaccine to be administered only to adults as of now: Sources

Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivity

Zydus Cadila’s COVID-19 vaccine ZyCoV-D gets EUA

Govt panel recommends EUA to Zydus Cadila’s 3-dose COVID-19 vaccine

4 more Indian pharma cos expected to start vaccine production by Oct-Nov, says Health Min

Zydus Cadila seeks emergency-use nod from DCGI for its Covid-19 vaccine

Zydus Cadila likely to seek EUA for its COVID-19 vaccine next week

Zydus Cadila introduces scratch code in critical drug packs to fight counterfeit menace

Zydus Cadila seeks DCGI nod for human clinical trials of antibodies cocktail to treat COVID-19

Zydus Cadila launches breast cancer treatment drug Ujvira

Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment

Zydus Cadila receives DCGI nod for NAFLD drug in India

Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1

Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

Guj: Modi reviews vaccine development at Zydus Cadila facility

PM reaches Ahmedabad to review coronavirus vaccine development

Zydus Cadila files investigational new drug application for COVID-19 treatment

Zydus Cadila gets USFDA nod for muscle relaxant injection

Mass production of COVID-19 vaccine to begin in India once scientists give nod: PM

Zydus Cadila launches COVID-19 drug Remdesivir in India

Bengaluru’s Zydus Cadila to start phase II clinical trials of COVID-19 vaccine

Latest Additions

Drawn end to rain-interrupted Gabba Test

Geethartha Chinthane – 128: Logic behind Rama’s exile and Pandavas’ incognito

Malpe: Fire breaks out at meeting room of Fisheries Department Office

Kerala HC rejects M M Lawrence’s daughters’ pleas to hand over his remains

Malpe: Goods vehicle carrying coconut coir catches fire

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.